20 results
8-K
ATOS
Atossa Therapeutics Inc
1 Jul 22
Regulation FD Disclosure
9:01am
or that the Neoadjuvant Study will commence.
Atossa continues to recruit participants for its ongoing Phase 2 clinical study of (Z)-endoxifen in premenopausal women
424B3
b13l fxcero
19 Apr 13
Prospectus supplement
12:00am
DEF 14A
lva rklppuiqo
15 Apr 13
Definitive proxy
12:00am
10-K
4q6savbmyjdtx
28 Mar 13
Annual report
12:00am
- Prev
- 1
- Next